Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Jan Máchal

1PUBLICATIONS

11CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jan 28, 2026

Long-term Subclinical Cardiotoxicity of Modern Cardiotoxic Treatment Protocols in Childhood Cancer Survivors Assessed by Cardiovascular Magnetic Resonance T1 Mapping and Circulatory Biomarkers.

Roman Panovský, Marie Tomandlová, Mary Luz Mojica-Pisciotti

Pageof 1

Frequent Collaborators

1 joint publications

Roman Panovský

1 joint publications

Marie Tomandlová

1 joint publications

Mary Luz Mojica-Pisciotti

1 joint publications

Tomáš Kepák

1 joint publications

Věra Feitová

1 joint publications

Jan Frič

1 joint publications

Marcela Hortová-Kohoutková

1 joint publications

Tomáš Holeček

1 joint publications

Josef Tomandl

1 joint publications

Lukáš Opatřil

Frequent Collaborators

1 joint publications

Roman Panovský

1 joint publications

Marie Tomandlová

1 joint publications

Mary Luz Mojica-Pisciotti

1 joint publications

Tomáš Kepák

Top Related Videos

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on : Mar 24, 2023

See more related videos

Top Related Videos

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers

Published on : Mar 24, 2023

See more related videos